And another commercial advertising or promotion case, no competition required

Educational Impact, Inc. v. Danielson, No. 14–937, 2015 WL 381332 (D.N.J. Jan. 28, 2015)
 
EI sued Charlotte Danielson and other entities for breach of contract, violations of the Lanham Act, unfair competition, tortious interference, and unjust enrichment.  Per the complaint: Danielson wrote a rubric to evaluate teacher performance, the “Framework for Teaching,” with iterations in 1996, 2007, 2011, and 2013. This rubric has been widely adopted.  EI makes professional development programs and services, and it contracted with one Danielson-run defendant to create a program based on the Framework for Teaching. The contract had an exclusivity/non-compete provision, which defendants allegedly breached by working with defendant Teachscape, a direct competitor of EI. 
 
Danielson allegedly initially maintained that the “psychometric assessment tool” she was working on with Teachscape would not compete with EI’s Framework for Teaching Online Program, but then she began working exclusively with Teachscape and allegedly created a directly competing program using the same rubric. In 2012, Teachscape began to represent that it was the “exclusive digital provider,” for Danielson’s new versions of the Framework for Teaching Evaluation Instrument, e.g., claiming that Teachscape’s products “are the only software products authorized for use with the 2011 and 2013 Editions.” Another defendant website similarly stated that only Teachscape could incorporate the 2011 and 2013 Framework for Teaching Evaluation Instruments in its software products.  EI allegedly discovered that Danielson had directed one defendant’s employees and contractors to download EI videos and use them in seminars and training programs. (Related copyright infringement suits against several school districts that were Teachscape customers were stayed given their dependence on the issues in this case.)
 
I won’t talk about the contract-based claims; suffice it to say that they remain alive.
 
As to the Lanham Act/unfair competition claims, they were based on statements that Teachscape’s products “are the only software products authorized for use with the 2011 and 2013 Editions” and “only Teachscape can incorporate the content of the Framework for Teaching Evaluation Instrument (2011 and 2013) in its software products.” Defendants argued, among other things, that their statements were true as applied to software programs (as opposed to online videos) and that the statements weren’t made in commercial advertising or promotion.
 
The court turned to the Gordon & Breach test for commercial advertising or promotion but, explicitly dealing with an outstanding issue from Lexmark, held that Gordon & Breach’s competition requirement no longer applies. “Here, although [one defendant] is not in direct competition with EI, the claims made on its website, if shown to be false, likely have the effect of limiting EI’s sales. Under current law, this allegation is sufficient to state a claim under the Lanham Act.”
 
The issues around falsity and exclusive rights couldn’t be resolved on a motion to dismiss. Among other things, “software” might include a program that uses online videos and PDF handouts, as EI’s program did. The complaint therefore stated a claim.
 
Some parts of the tortious interference claims survived too.
Posted in commercial speech, http://schemas.google.com/blogger/2008/kind#post | Leave a comment

commercial advertising or promotion post-Lexmark

Tobinick v. Novella, No. 9:14–CV–80781, 2015 WL 1191267 (S.D. Fla. Mar. 16, 2015)
 
Steven Novella wrote two articles criticizing the practice of Edward Tobinick, “a doctor who provides medical treatment to patients with ‘unmet medical needs’ via two institutes—‘Edward Lewis Tobinick M.D.,’ a California medical corporation, and ‘INR PLLC,’ a Florida professional limited liability company—both doing business as the ‘Institute of Neurological Recovery.’” Novella published the first article, “Enbrel for Stroke and Alzheimer’s”, on May 8, 2013 in response to a piece published in the Los Angeles Times. As Novella described it,
 
The [Times] story revolves around Dr. Edward Tobinick and his practice of perispinal etanercept (Enbrel) for a long and apparently growing list of conditions. Enbrel is an FDA-approved drug for the treatment of severe rheumatoid arthritis. It works by inhibiting tumor necrosis factor (TNF), which is a group of cytokines that are part of the immune system and cause cell death. Enbrel, therefore, can be a powerful anti-inflammatory drug. Tobinick is using Enbrel for many off-label indications, one of which is Alzheimer’s disease (the focus of the LA Times story).
 
“The allegedly false statements in the first article concern the viability of Plaintiff Tobinick’s treatments, the scientific literature discussing those treatments, the size and locations of Plaintiff Tobinick’s Institutes, and, by implication, the categorization of Plaintiff Tobinick’s practice as ‘health fraud.’” Novella published the second article, “Another Lawsuit To Suppress Legitimate Criticism—This Time SBM” on July 23, 2014, after plaintiffs sued. It mostly restated the content of the first article, though plaintiffs also alleged that it was false and misleading to say that “there have been no double-blind placebo-controlled clinical trials of the treatment provided by the Plaintiffs.”
 
Plaintiffs sued Novella as well as the Society for Science-Based Medicine, whose responsibility for the articles was “far from clear.”  The articles weren’t posted on the Society’s website, though there’s a link to the first article on its wiki.  The articles were and remained posted on the Science-Based Medicine blog(SBM blog).  Novella was involved both with the blog and the Society, as “Founder and Executive Editor” of the blog, and as a Board member and Officer of the Society. Plaintiffs argued that the SBM Blog was part of the Society’s structure and internet presence, such that the Society should be liable for the content of the articles.
 
Plaintiffs sued for violations of the Lanham Act/unfair competition, trade libel, and libel.
 
Treating the defendants’ motion as a motion for summary judgment, the court found that the Lanham Act claims against the Society had to fail as the blog posts weren’t “commercial advertising or promotion,” at least with respect to the Society, and that the libel claims had to be dismissed without prejudice because plaintiffs failed to provide the requisite pre-suit notice, but that it couldn’t yet be determined whether §230 barred the libel claims against the Society.
 
The Society is a §503(c)(3) nonprofit with an educational mission promoting “the concept of science-based medicine—that all health care practices and products need to be rooted in a single, science-based standard of care, delivered within a consistent framework of scientific standards.” It has a “Donate” button on its homepage, and there are both free and paid memberships.  It has a web store with links to purchase eBooks comprised of compiled SBM Blog posts; the eBooks are free with Society membership.
 
The evidence that the Society was responsible for the blog consisted primarily of various statements made by Board members and Officers of the Society, as well as the Society itself, that the SBM Blog is one of two blogs “for the [S]ociety.” There was notable cross-membership, and the two websites supported and encouraged cross-traffic by linking to each other and by offering the “Science–Based Medicine” eBooks. However, there were also distinctions: the SBM blog predated the Society by at least five years; donations made to the SBM Blog do not go to the Society but rather to the New England Skeptical Society; and the Society stated that Novella published the articles without the Society’s knowledge, consent, or participation.  The relationship between the Society and the SBM blog was a material fact that precluded resolution of the CDA immunity argument.   
 
However, no reasonable jury could find that the allegedly false/defamatory statements constituted commercial speech as to the Society. The Eleventh Circuit uses the Gordon & Breach test for “commercial advertising or promotion,” except that, after Lexmark, the requirement that the parties be competitors is apparently abrogated.  That leaves (1) commercial speech (3) for the purpose of influencing consumers to buy defendant’s goods or services that are (4) disseminated sufficiently to the relevant purchasing public to constitute “advertising” or “promotion” within that industry.
 
To evaluate “commercial speech,” we turn to the First Amendment test. Core commercial speech does no more than propose a commercial transaction.  But more broadly, commercial speech is assessed by whether it is in the form of an ad, whether it refers to specific products sold by the defendant, and whether the defendant had an economic motivation for the speech. Plaintiffs argued that the science-based medicine movement was an economic enterprise, making the speech commercial, as did the sale of eBooks and memberships, along with the acceptance of donations.
 
Nope. Neither article proposed a commercial transaction.  They were not “expression related solely to the economic interests of the speaker and its audience,” but instead “clearly state their intent to raise public awareness about issues pertaining to Plaintiffs’ treatments, a goal in line with the Society’s educational mission.” They did discuss the price of the treatments, but that didn’t make them relate “solely” to the economic interests of the speaker and the audience.  In Bolger, by contrast, the materials found to be commercial speech used an ongoing public debate to advertise the defendant’s own products, which were referenced in the informational pamphlets the defendant distributed, and the defendant conceded that the pamphlets were ads.
 
Here, “[t]he Society published articles questioning the viability of Plaintiffs’ medical practices and the scientific rigor of their research. The only ‘products’ referenced within the first article are Plaintiffs’ own treatments; no competitors’ products—let alone products offered for sale by the Society—are cited in the articles.”  Novella’s medical practice and the drugs he used appeared in the second article “only to illustrate Novella’s belief that he and Plaintiffs are not competitors.”  This was explicitly a response to the lawsuit, not an independent plug for Novella’s practice—which, the court noted, was not the Society’s practice.
 
Furthermore, the Society was a nonprofit:
 
Like nearly every not-for-profit corporation, it seeks to support itself by soliciting donations and offering products for sale. That does not render its speech commercial, particularly where, as here, there is nothing in the record to indicate that the articles containing the allegedly false and/or defamatory statements do not remain free to view online. The articles simply do not constitute commercial speech, at least with respect to the Society.
 
Florida requires pre-suit notice of libel claims to media defendants, which was not properly given here.  To determine whether the Society was a media defendant, the court asked whether it engaged “in the traditional function of the news media,” which is “to initiate ‘uninhibited, robust, and wide-open debate on public issues.’” Media defendants are not just those who “impartially disseminate information,” or “issue unsolicited, disinterested and neutral commentary as to matters of public interest,” but includes those who “editorialize as to matters of public interest without being commissioned to do so by [their] clients.” The Society’s stated mission of educating the public qualified it as a media defendant, since there was no evidence that any of the allegedly false and/or defamatory statements were commissioned by clients. Dismissed with leave to refile.
Posted in 230, commercial speech, defamation, http://schemas.google.com/blogger/2008/kind#post | Leave a comment

The photocopier and the arc of history

Smithsonian Magazine on the politics and culture of easy personal copying (version one).

Posted in copying | Leave a comment

Materials on privacy and surveillance

Terry Diggs, an adjunct at U.C. Hastings Law, alerted me to a website she put together for a privacy/surveillance website with both text and video materials of possible interest to teachers of the subject.  (See the video and MCLE sections for more.)

Posted in privacy | Leave a comment

picture of refurbished equipment wasn’t literally false passing off

Stolle Machinery Co., LLC v. RAM Precision Industries, — Fed.Appx. —-, 2015 WL 1137429, No. 13–4103 (6th Cir. Mar. 16, 2015)
 
Stolle makes used to produce food and beverage cans. Stolle’s former employee, Shu An moved back to China, and in early 2004 started a competitor company, SLAC. Stolle alleged that An stole its trade secrets, including technical drawings, in order to launch his business.
 
In 2003, Stolle sent a letter to its suppliers alerting them to Stolle’s concerns about An’s behavior. In response, An retained counsel in the US, who sent a letter to Stolle in February 2004 accusing Stolle of “defamatory, or at best, very aggressive tactics, to prevent Mr. An from earning a livelihood.” Stolle replied that although “Stolle Machinery does not agree with your characterization of communications Stolle had, or is alleged to have had, with various companies regarding your client[,] … Stolle does not anticipate having any communication with other companies regarding your client in the future.” Stolle’s explanation for taking no further action at that time was “How do you secure drawings from a Chinese nationalist who is hiding in China? I don’t know. … If he was an American living in the U.S., I probably would have done something more. … How do I go after him in Jiangsu, wherever he is hiding.”  Over the years, Stolle got more information about An’s copying, and even contacted the FBI, but couldn’t prove espionage.
 
In late 2009, Stolle’s director of sales left the company and accepted a job at RAM Precision Industries, a firm that had been one of Stolle’s parts suppliers. In early 2010, Stolle learned that Fultz and An had jointly met with customers in China during the previous month. “At this point the wheels of this litigation finally began to turn.”
 
The district court found that only a claim against An for copyright infringement could survive summary judgment; the court of appeals found that there was personal jurisdiction and mostly affirmed but reversed the grant of summary judgment to SLAC on Stolle’s claim of trade secret misappropriation because there was a genuine issue of material fact about when the statute of limitations began to run against SLAC, which didn’t exist during the beginning of these events and thus couldn’t benefit from events before its existence.
 
Lanham Act/state Deceptive Trade Practices Act: Stolle alleged reverse passing off because An and SLAC were incorporating Stolle’s trade secrets into their own machine and passing it off as their own. This claim failed as a matter of law under Dastar.  (Small but notable point: by treating the state law claims as governed by Dastar, which interpreted the meaning of “origin” under the Lanham Act, the court is making a potentially significant move as to claims that are barred by Dastar but would not have been preempted by copyright/patent law—a state could in theory decide to read “origin” more broadly, right?)
 
An argument in the reply brief that SLAC passed off a refurbished Stolle machine as a new SLAC machine would have constituted a cognizable Lanham Act violation if it had been made in time.
 
Stolle’s false advertising claim arose from a photo of a piece of Stolle machinery that had been refurbished by SLAC. Stolle alleged that SLAC was depicting Stolle equipment bearing Stolle’s trademark as SLAC’s own equipment. But to get damages, Stolle needed to show literal falsity or evidence of actual deception, and to get an injunction it would need to show a tendency to deceive. And Stolle didn’t provide evidence that SLAC was doing anything other than what it said: “posting the picture on their website to illustrate that they were in the business of refurbishing Stolle machines.” Without further context, the court didn’t find literal falsity, and Stolle didn’t show actual deception or a tendency to mislead.
 
Finally, Stolle argued that SLAC shouldn’t have gotten summary judgment on Stolle’s copyright infringement claim.  There was evidence that An copied Stolle’s drawings, but not that SLAC did.  The allegedly infringing drawings were labeled February 13, 2003, when SLAC didn’t exist, and there was no evidence of copying after SLAC was formed. “The use of copies to manufacture a product does not, by itself, constitute copyright infringement: to hold otherwise would transform a copyright into a patent.”
 
Posted in copyright, dastar, http://schemas.google.com/blogger/2008/kind#post, trade secrets | Leave a comment

Amicus brief in Dryer v. NFL

Mark McKenna and I drafted a law professors’ amicus in Dryer v. NFL, a right of publicity case now on appeal in the 8th Circuit. We argued for a strong First Amendment standard for non-advertising speech as well as for copyright preemption of right of publicity claims based on ordinary exploitation of copyrighted works.

Posted in first amendment, http://schemas.google.com/blogger/2008/kind#post, my writings, preemption, right of publicity, trademark | Leave a comment

Pleading around Dastar?

Kowalski v. Anova Food, LLC, 2014 WL 8105172, No. 11–00795 (D. Hawai’i Dec. 31, 2014)
 
Kowalski owns a patent entitled “Process For Manufacturing Tasteless Super–Purified Smoke For Treating Seafood To Be Frozen And Thawed.” He sued Anova for patent infringement and false advertising under the Lanham Act.  In 1999, he sent a notice of infringement letter, and Anova’s predecessor in interest replied that it would liquidate its inventory of tasteless smoke tuna.  In 2000, he sent another letter.  A former president of Anova’s predecessor declared that he met Kowalski in 2005 and asked him if he was going to sue, and that Kowalski said no, but Kowalski disputed this.  Because of the disputed facts, summary judgment on Anova’s equitable estoppel defense was inappropriate.  Also, though the laches defense was not barred by Petrella according to Federal Circuit precedent, the presumption of laches given delay over 6 years was rebutted because Kowalski’s engagement in other litigation made its delay reasonable, and Anova knew of (and even participated in) other litigation around the validity of the patent.
 
As for the Lanham Act claim, Kowalski alleged that Anova misrepresented the process Anova used to treat its fish. Anova argued that this wasn’t a claim about the nature, characteristics, or qualities of its products, but merely an argument that Kowalski was the rightful owner of the process used, which couldn’t be a Lanham Act claim under Dastar/Baden. The court disagreed and found that Kowalski alleged that Anova hadn’t used the “Clearsmoke” process as advertised and thus misrepresented the characteristics and qualities of its fish.  Hard to tell whether this is really just an evasion of Dastar; one question that seems likely to be relevant is whether the difference between Clearsmoke and whatever Anova allegedly used instead would be material to consumers.
Posted in http://schemas.google.com/blogger/2008/kind#post, patent | Leave a comment

"I’m not a regular Republican, I’m a cool Republican"

House GOP attempts to explain its immigration policy in .gif form.  There’s probably an interesting gender analysis to be done here about the use of reaction .gifs of women making extremely expressive faces but not saying much.  HT Phil Schrag.

Bonus question: in a state that does not require commercial advantage to the defendant, just advantage, is the GOP post a violation of the right of publicity?

Posted in copying, http://schemas.google.com/blogger/2008/kind#post, right of publicity | Leave a comment

How does the doctrine of foreign equivalents apply to scandalousness?

Restaurant with questionable name opens in Arlington.  Unregistrable?

HT Zach Schrag
Posted in trademark | Leave a comment

court certifies 11 state classes in "All Natural" challenge

In re ConAgra Foods, Inc., No. CV 11–05379, 2015 WL 1062756 (C.D. Cal. Feb. 23, 2015)
 
I’ve tried to limit discussion of many issues in this huge opinion (40,000 words without footnotes). Plaintiffs, consumers from eleven different states, alleged that they bought Wesson Oils because ConAgra deceptively marketed them as “100% Natural” on the front label, even though they were made with GMOs. They alleged claims for violation of state consumer protection laws, breach of express warranty, breach of the implied warranty of merchantability, and unjust enrichment.
 
Given Dukes, the court applied Daubert to the experts at the class stage.  Plaintiffs’ expert Colin Weir was Vice President of Economics and Technology, Inc. (“ETI”), a research and consulting firm specializing in economics, statistics, regulation, and public policy. He opined that it would be possible to determine damages “with a reasonable degree of specificity, certainty, and accuracy, attributable to ConAgra’s conduct of placing the ‘100% Natural’ claim on the label of every bottle of Wesson Oil by applying the scientifically valid economic methodology of hedonic regression to common, class-wide, aggregate historical retail price and attribute data for Wesson Oil and competing cooking oils to calculate a class wide Price Premium, and then multiplying that Price Premium by the total retail amounts all Class Members paid for Wesson Oil to yield total class-wide damages.”  This would require conjoint analysis.  The court previously found that he failed to provide a reliable damages model including the relevant variables or data, even if the methodologies he described were capable of calculating damges in theory.  ConAgra argued that he still failed to identify data in his possesssion to which hedonic regression could be applied, or relevant variables.  However, the court found he’d remedied the earlier deficiencies by preparing a preliminary regression model to measure price/price premium. He analyzed twenty product attributes, using data from various spreadsheets and reports reflecting historical price, cost, profit and attribute information for Wesson Oils and competitor brands.  He acknowledged that more geographically and temporally specific data could be obtained and used for more refined regressions.
 
ConAgra argued that the data he had wasn’t useful in performing hedonic regression analysis, and that the data were incomplete and didn’t control for geography, sales channels, or retailers.  Its expert opined that Weir’s proposed methodology was flawed.  The court found that Weir’s testimony was sufficiently reliable; more geographic information was available and while Weir might not obtain the same price premium results once it was included, that just meant that his testimony might not be helpful to plaintiffs, not that it was unreliable.
 
ConAgra also sought to exclude the declaration of Elizabeth Howlett, who opined on a consumer survey about GMOs.  The survey described GMOs in a way that “alarmed and confused survey respondents” (including “bacteria,” “virus,” or “toxic to certain insects”), and it had a small sample size and high nonresponse rate. While most challenges to a survey go to weight rather than admissibility, the issues here were so severe that this survey didn’t satisfy Daubert.  Given that 51% of respondents responded incorrectly to a question designed to ensure they understood the definition of the GMO process, and that Howlett didn’t participate in designing and administering the survey, her opinion that it properly defined the GMO process was insufficient.  The sample size was a problem because the court didn’t know the sampling method used and because the sample didn’t approximate the relevant characteristics of the customer population.  “[G]iven Howlett’s inability to validate that the survey was reliably designed and administered, such concerns reasonably suggest that the survey’s methodology may be flawed.”
 
However, Howlett’s academic training and practical experience qualified her to testify to the calculation of damages using a conjoint analysis. Conjoint analysis would be used to assess the percentage of the “100% Natural” claim that was attributable to the absence of GMOs as opposed to other “non-natural” aspects of the Wesson Oils. Howlett sufficiently explained why she chose the attributes she did, and had sufficient experience with conjoint analysis for her testimony to be deemed reliable.
ConAgra also objected to the testimony of nine named plaintiffs, eight of whom said that they’d “very interested” in buying Wesson Oils labeled “100% Natural” if they did not contain GMOs, and that they “might consider” or “will consider” purchasing Wesson Oils in the future if they continue to contain GMOs and ConAgra stops labeling them “100% Natural.” ConAgra argued that these were shams rather than true witness testimony. The fact that attorneys may have prepared the declarations was standard; declarants are under penalty of perjury and can refuse to sign any document that is incorrect or inconsistent with their recollections or beliefs.  Their statements that they’d consider buying Wesson oil again weren’t shams; the declarations clarified earlier claims that plaintiffs had stopped buying Wesson oil. “While the declarations may negatively affect plaintiffs’ ability to prove materiality, causation, and/or reliance, this does not compel the conclusion that they are false or directly contradictory of prior testimony.”
 
Turning to the motion for class certification, plaintiffs sought classes for California, Colorado, Florida, Illinois, Indiana, Nebraska, New York, Ohio, Oregon, South Dakota, and Texas consumers.
 
ConAgra argued that the named plaintiffs lacked standing for want of injury, given that after they sued, they continued to purchase cooking oils and other products that were labeled “natural” but contained non-organic GMO ingredients, and they didn’t know what price they paid for Wesson despite alleging a “premium.” The court disagreed. Though their subsequent purchases, and their willingness to buy Wesson oil again even if it still had GMOs, might seriously undercut their claim that “100% Natural” was material, that didn’t deprive them of standing.  Nor did the fact that plaintiffs couldn’t recall the exact price they paid deprived them of standing, given the potential for a workable damages methodology.
 
Ascertainability: ConAgra argued that the classes were not ascertainable because there was no way to determine the identity of consumers who purchased its products. The court disagreed that self-certification was impossible; ConAgra’s position would “effectively prohibit class actions involving low priced consumer goods—the very type of claims that would not be filed individually—thereby upending ‘[t]he policy at the very core of the class action mechanism.’” Because every putative class member has been exposed to the alleged misrepresentation, the fact that some class members may have not been injured by the “100% Natural” claim does not render the class unascertainable.
 
Numerosity: of course. Commonality: all the consumers were exposed to the challenged label. Typicality: ConAgra argued that the named plaintiffs’ claims weren’t typical because the “100% Natural” label was not a significant factor driving purchases of Wesson Oil.  Its survey showed no statistically significant difference between the purchasing decisions of survey respondents shown a “100% Natural” label and those who saw a label without the phrase. Only 5–6 percent of respondents who saw the “100% Natural” label mentioned “natural” ingredients when describing why they would or would not buy a Wesson Oil product, and identifying the factors that were important to them when purchasing cooking oil.  But typicality asks whether the named plaintiffs’ claims arise from the same course of conduct as the class members’ claims and whether they’re subject to unique defenses; ConAgra’s arguments didn’t show atypicality.
 
Adequacy: yep.
 
Plaintiffs sought to certify proposed classes separately for injunctive relief and damages.  On injunctive relief, plaintiffs sought to show that they could represent the class because they’d consider buying Wesson again.  They argued that their evidence wasn’t speculative, merely conditional: if ConAgra changed its conduct, they’d buy Wesson again. The court didn’t agree. Considering a future purchase wasn’t concrete enough to show a sufficient likelihood of being harmed in the future
 
Damages: for 23(b)(3) certification, plaintiffs had to show that common issues predominated. The key issues here are reliance and causation.  First, the court had to determine whether a classwide inference of reliance and causation was available upon a showing of falsity and materiality under each state’s laws.  California: yes, for consumer protection claims and express warranty claims (privity was required for breach of implied warranty, and that couldn’t be shown here on a class basis).
 
Colorado: A classwide inference of reliance and causation could be made for material misrepresentations under Colorado consumer protection law and warranty claims, but not unjust enrichment, which would require individual proof of causation.
 
Florida: Similar: state consumer protection claims could be adjudicated on a classwide basis, but not unjust enrichment. “Even if plaintiffs can prove that the ‘100% Natural’ was false, it does not necessarily follow that ConAgra’s retention of the full purchase price would be inequitable with respect to a consumer who did not notice or did not rely on the ‘100% Natural’ claim.”
 
Illinois: While reliance wasn’t required, proximate causation was a requirement under Illinois consumer protection law; individual issues would almost always be present, but wouldn’t necessarily predominate.  Where the representation being challenged was made to all putative class members, “Illinois courts have concluded that causation is susceptible of classwide proof and that individualized inquiries concerning causation do not predominate if plaintiffs are able to adduce sufficient evidence that the representation was material.”  Unjust enrichment would stand or fall with the statutory claim, so was subject to the same analysis.
 
Indiana: Here there were only warranty and unjust enrichment claims.  Uniform misrepresentations allowed common issues to predominate for unjust enrichment purposes, whereas the express warranty claims required either privity or a showing of reliance, and there was no showing that Indiana accepted reliance as capable of classwide proof. By contrast, breach of implied warranty of merchantability required proximate cause, and plaintiffs argued that their price premium theory showed proximate cause of harm for every class member.  The court agreed.
 
Nebraska: These were also warranty and unjust enrichment claims, and the court reached the same results.
 
New York: Plaintiffs alleged violation of the New York GBL, breach of express warranty, and unjust enrichment. Proof of reliance and scienter are not elements of a GBL claim; likelihood of misleading a reasonable consumer was the key issue and could be established on a classwide basis.  Materiality could be proved classwide for breach of express warranty.  But an unjust enrichment class couldn’t be certified because individualized inquiries as to whether “equity and good conscience require restitution” are not susceptible of classwide proof under New York law.
 
Ohio: Plaintiffs alleged only state consumer protection law violations.  In Ohio, a classwide inference of reliance is permitted where defendant’s fraudulent or deceptive conduct is common to all consumers, so common issues could predominate.  
 
Oregon: Plaintiffs alleged violations of state consumer protection law and unjust enrichment.  Here again, causation and reliance were susceptible of classwide proof for consumer protection law, and also unjust enrichment could be given class treatment because the putative class members were subjected to “uniform treatment” by the defendant.
 
South Dakota: Same asserted violations as Oregon, but no South Dakota precedent either way on whether reliance or causation could be proved on a classwide basis for consumer protection law violations. The court predicted that they could be upon a showing of materiality, guided by the “broad, remedial purpose” of South Dakota’s consumer protection law and by the South Dakota Supreme Court’s suggestion that “class certification ‘is favored by courts in questionable cases.’” Also common issues predominated with unjust enrichment because of the defendant’s uniform conduct.
 
Texas: Same claims, but here only the consumer protection law claims survived; for unjust enrichment, the Texas Supreme Court had held that, even in situations where the price paid by class members to the defendant, is uniform, “individual differences between each class member’s experience” will necessitate individualized inquiries to “determine in whose favor the equities weigh in resolving [class members’] claims.”
 
Whew.  All of this depended on whether materiality could be proved on a classwide basis; the court therefore turned to that issue.  Plaintiffs offered various third party surveys to show materiality of “100% Natural,” such as a 2014 report by the Consumer Reports National Research Center, which surveyed a nationally representative sample of consumers and found that 59% look for a “natural” claim when shopping for packaged or processed foods such as Wesson Oils. A 2010 survey also found that 65% of respondents were “somewhat interested” or “very interested” in purchasing natural products and a substantial majority of consumers attested that it was worth paying more for “natural” products.  Plaintiffs also cited some of ConAgra’s market research, which purportedly showed that consumers exposed to a “100% Natural” or “Natural” claim on ConAgra product labels generally consider the representation a significant factor in their purchasing decisions, as well as ConAgra internal strategy documents identifying the claim as a favorable one.  None of the surveys specifically linked consumers’ understanding of “100% Natural” to whether they thought that a product with that label had no GMO ingredients, but they did tend to show materiality of the claim.
 
Plaintiffs also cited surveys to show that consumers believe that “Natural” means without GMOs, such as the Consumer Reports survey, in which 64% of respondents believed that a “natural” claim on food products meant that the product contained “no GMOs” or “genetically modified ingredients.” Two other studies by the Hartman Group found that a majority of consumers understood “natural” to mean an “absence of genetically modified foods,” and that “[c]onsumers perceive [GMO] foods as inherently unnatural and worry about adverse health effects” from such foods. A HealthFocus International study also concluded that a substantial majority of consumers associate a “natural” claim with the absence of GMOs. Moreover, plaintiffs submitted evidence that the company received consumer complaints about the “100% Natural” label on Wesson Oils after consumers discovered that they contained GMOs.
 
This was enough of a showing of materiality for purposes of class certification. Plaintiffs didn’t need to show that every customer would find the claim material or believe it meant no GMOs.  Instead, they only needed to show that a reasonable consumer would understand it that way and find it material.  Courts have accepted materiality claims from significantly smaller percentages.
ConAgra argued that the claim couldn’t be material because the FDA has refused to designate genetically engineered foods and food ingredients non-natural and has concluded that the presence of GMOs is not a “material fact” that must be disclosed under FDA regulations. But the FDA’s view of genetically engineered foods wasn’t the relevant question, which was what a reasonable consumer would have thought.  Plaintiffs’ possible interest in purchasing Wesson again could support an inference of immateriality, but that didn’t show immateriality to a reasonable consumer, especially in light of the survey evidence.
 
Comcast says that Rule 23(b)(3) is satisfied only if plaintiffs can show that “damages are capable of measurement on a classwide basis,” using a method of proof tied to plaintiffs’ theory of liability. Previously, the court found Weir’s calculations insufficiently specific, since consumers might attribute multiple possible characteristics to a “natural” label, and Weir didn’t isolate the price premium from misleading consumers about GMOs.  (Hmm.  I don’t see why that matters, since if it’s deceptive to use “natural” when a product has GMOs, then the product shouldn’t use the term and those other meanings would also be unavailable to consumers and unable to bring their share of the price premium.  I doubt “GMOs, but otherwise natural” is really an available message for ConAgra.)  Here, Weir’s methodology plus Howlett’s conjoint analysis were sufficient in combination.  Howlett proposed to use consumer surveys to segregate the percentage of the price premium specifically attributable to a customer’s belief that “100% Natural” means “no GMOs,” and multiplying that times the premium “would necessarily produce a damage figure attributable solely to ConAgra’s alleged misconduct—i.e., misleading consumers to believe that Wesson Oils contain no GMOs by placing a ‘100% Natural’ label on the products.”  Criticisms of Howlett’s methods were not dispositive at this stage.
ConAgra next argued that individualized inquiries would be required to figure out how many bottles, what sizes, etc. individual consumers bought. The damages inquiry could account for that.  Thus, predominance was present.
 
Superiority:  yep. ConAgra argued that eleven state classes would be unmanageable.  The court agreed with plaintiffs that separate classes avoided choice of law concerns; that the laws all fell into consistent patterns; and that the warranty claims were all based on the same statutory test. “Under the various consumer protection statutes, plaintiffs must show, for example, that ConAgra’s conduct is deceptive and misleads reasonable consumers and/or class members.”  The surviving unjust enrichment claims all involved “substantially the same question—whether ConAgra received some benefit from plaintiffs that it would be inequitable to allow it to keep in light of its conduct.” So too with the breach of warranty claims.
 
Posted in california, class actions, consumer protection, http://schemas.google.com/blogger/2008/kind#post, unfairness | Leave a comment